These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38967509)

  • 1. 68Ga-NODAGA-Exendin-4 PET/CT Findings in a Case of Metastatic Insulinoma With Refractory Hypoglycemia Controlled by 90Y Transarterial Radioembolization.
    Şahin R; Rakıcı İT; Baloğlu MC; Şahin ÖF; Çermik TF
    Clin Nucl Med; 2024 Aug; 49(8):e392-e393. PubMed ID: 38967509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of Multiple Pancreatic Neuroendocrine Tumors Identified by 68Ga-DOTANOC and 68Ga-Exendin-4 PET/CT in a Patient with Endogenous Hyperinsulinemic Hypoglycemia and Multiple Endocrine Neoplasia 1.
    Xu J; Xu X; Zhang M; Liu W; Chen J; Song S
    Neuroendocrinology; 2024; 114(9):866-871. PubMed ID: 38471465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of intractable hypoglycemia with Yttirum-90 radioembolization in a patient with malignant insulinoma.
    Chandra P; Yarandi SS; Khazai N; Jacobs S; Umpierrez GE
    Am J Med Sci; 2010 Nov; 340(5):414-7. PubMed ID: 20724903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagon-Like Peptide-1 Receptor PET/CT with 68Ga-NOTA-Exendin-4 for Detecting Localized Insulinoma: A Prospective Cohort Study.
    Luo Y; Pan Q; Yao S; Yu M; Wu W; Xue H; Kiesewetter DO; Zhu Z; Li F; Zhao Y; Chen X
    J Nucl Med; 2016 May; 57(5):715-20. PubMed ID: 26795291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ectopic insulinoma diagnosed by 68Ga-Exendin-4 PET/CT: A case report and review of literature.
    Zhang X; Jia H; Li F; Fang C; Zhen J; He Q; Liu M
    Medicine (Baltimore); 2021 Apr; 100(13):e25076. PubMed ID: 33787590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of metastatic insulinoma by positron emission tomography with [(68)ga]exendin-4-a case report.
    Eriksson O; Velikyan I; Selvaraju RK; Kandeel F; Johansson L; Antoni G; Eriksson B; Sörensen J; Korsgren O
    J Clin Endocrinol Metab; 2014 May; 99(5):1519-24. PubMed ID: 24512490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant insulinoma: 18F-DOPA and 68Ga-DOTATATE PET/CT and treatment with 177Lu-DOTATATE.
    Erhamamcı S; Sager S; Asa S; Uslu L; Akgun E; Sonmezoglu K
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(6):383-386. PubMed ID: 32487444
    [No Abstract]   [Full Text] [Related]  

  • 8.
    Sakaki K; Murakami T; Fujimoto H; Shimizu Y; Miyake KK; Otani D; Kiyobayashi S; Okada T; Fujimoto M; Hakata T; Yamauchi I; Shimada K; Shimizu H; Nagai K; Nakamoto Y; Inagaki N
    Front Endocrinol (Lausanne); 2023; 14():1245573. PubMed ID: 37720533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 68Ga-NOTA-Exendin-4 PET/CT in Localization of an Occult Insulinoma and Appearance of Coexisting Esophageal Carcinoma.
    Luo Y; Li N; Kiesewetter DO; Chen X; Li F
    Clin Nucl Med; 2016 Apr; 41(4):341-3. PubMed ID: 26647001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Ga(68) -DOTA-exendin-4 PET/CT to localize an occult insulinoma.
    Cuthbertson DJ; Banks M; Khoo B; Antwi K; Christ E; Campbell F; Raraty M; Wild D
    Clin Endocrinol (Oxf); 2016 May; 84(5):789-91. PubMed ID: 26562613
    [No Abstract]   [Full Text] [Related]  

  • 11. Internal pair production of 90Y permits hepatic localization of microspheres using routine PET: proof of concept.
    Gates VL; Esmail AA; Marshall K; Spies S; Salem R
    J Nucl Med; 2011 Jan; 52(1):72-6. PubMed ID: 21149493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [(68)Ga-exendin-4 PET-CT for the localization of occult insulinomas: a prospective cohort study].
    Luo YP; Pan QQ; Li F; Yu M; Xing XP; Zhang TP; Zhao YP
    Zhonghua Wai Ke Za Zhi; 2018 Nov; 56(11):837-842. PubMed ID: 30392304
    [No Abstract]   [Full Text] [Related]  

  • 13. Localization of Hidden Insulinomas with ⁶⁸Ga-DOTA-Exendin-4 PET/CT: A Pilot Study.
    Antwi K; Fani M; Nicolas G; Rottenburger C; Heye T; Reubi JC; Gloor B; Christ E; Wild D
    J Nucl Med; 2015 Jul; 56(7):1075-8. PubMed ID: 25999434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of yttrium-90 in the management of unresectable hepatocellular carcinoma and hepatic metastases.
    Kousik V; Promila P; Verma R; Gupta A
    Indian J Gastroenterol; 2016 May; 35(3):179-85. PubMed ID: 27185180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 68Ga-NOTA-exendin-4 PET/CT in detection of occult insulinoma and evaluation of physiological uptake.
    Luo Y; Yu M; Pan Q; Wu W; Zhang T; Kiesewetter DO; Zhu Z; Li F; Chen X; Zhao Y
    Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):531-2. PubMed ID: 25398421
    [No Abstract]   [Full Text] [Related]  

  • 16. 68Ga-Exendin-4 PET/CT Differentiates Insulinoma From Accessory Spleen in a Patient Presenting Indeterminate MRI and 68Ga-DOTATATE PET/CT Findings.
    Pang Y; Meng T; Shang Q; Chen Z; Chen H
    Clin Nucl Med; 2022 Mar; 47(3):265-267. PubMed ID: 34507334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Volume Replacement Fluid Demarks Benign Insulinoma With 68Ga-DOTA-Exendin-4 PET/CT.
    Antwi K; Nicolas G; Fani M; Christ E; Wild D
    Clin Nucl Med; 2019 May; 44(5):e347-e348. PubMed ID: 30889001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Validation of an Analytical HPLC Method to Assess Chemical and Radiochemical Purity of [
    Migliari S; Sammartano A; Boss M; Gotthardt M; Scarlattei M; Baldari G; Silva C; Bonadonna RC; Ruffini L
    Molecules; 2022 Jan; 27(2):. PubMed ID: 35056858
    [No Abstract]   [Full Text] [Related]  

  • 19. High quality imaging and dosimetry for yttrium-90 (
    Duan H; Khalaf MH; Ferri V; Baratto L; Srinivas SM; Sze DY; Iagaru A
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2426-2436. PubMed ID: 33443618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 68Ga DOTA-Exendin PET/CT for Detection of Insulinoma in a Patient With Persistent Hyperinsulinemic Hypoglycemia.
    Parihar AS; Vadi SK; Kumar R; Mittal BR; Singh H; Bal A; Walia R; Shukla J; Sinha SK
    Clin Nucl Med; 2018 Aug; 43(8):e285-e286. PubMed ID: 29877881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.